Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding

Jacob E. Kurlander, Danielle Helminski, Alex N. Kokaly, Caroline R. Richardson, Raymond De Vries, Sameer D. Saini and Sarah L. Krein
The Annals of Family Medicine January 2022, 20 (1) 5-11; DOI: https://doi.org/10.1370/afm.2734
Jacob E. Kurlander
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan
3Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jkurland@umich.edu
Danielle Helminski
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex N. Kokaly
4UCLA Health Department of Medicine, Los Angeles, California
MD, MHSA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline R. Richardson
2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan
5Department of Family Medicine, University of Michigan, Ann Arbor, Michigan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond De Vries
2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan
6Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan
7Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sameer D. Saini
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan
3Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah L. Krein
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan
3Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan
PhD, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1.

    Participant Characteristics

    Participants (n = 15)No. (%)Participants (n = 15)No. (%)
    SpecialtyYears of practice
        Primary care5 (33.3)    1–55 (33.3)
        Cardiology4 (26.7)    6–106 (40.0)
        Gastroenterology3 (20)    11–151 (6.7)
        Vascular surgery3 (20)    16–201 (6.7)
        Female5 (33.3)    21 +2 (13.3)
    • View popup
    Table 2.

    Supporting Quotes for PPI Prescribing Practices

    Approach to Use of PPIs
    Primary care
    [PCP 3] “I can’t think of the last time I started [a PPI] for gastroprotection, but people tend to be on it already.”
    [PCP 2]
    Interviewer: “So, how do you tend to use [PPIs] in your patients?”
    Response: “GERD, GERD, and GERD. So, that’s number 1. And number 2 is as an offset to nonsteroidal therapy.”
    [PCP 1] “I’m more likely thinking about can I take that PPI away than I am thinking about what can I start to prevent an ulcer?”
    Cardiology
    [Cardiologist 1] “For example, if I had a post- [ST-elevation myocardial infarction] patient that needed to be on aspirin and Plavix, and they had a big apical thrombus and they needed to be on Coumadin...and they are going to be on triple therapy for a month, then I would probably just put them on a PPI prophylactically, just because it’s like definitely a higher bleeding risk to be on triple therapy...”
    [Cardiologist 4]
    Interviewer: “How often do you tend to prescribe it in patients who are asymptomatic just for the purposes of preventing bleeding?”
    Response: “I can’t think of times when I have done that.”
    [Cardiologist 3] “So, I put everybody I see and start on—even if they are on it, but I make sure everybody—if I have a patient who is on dual antiplatelet therapy, they go on a PPI. I pretty much—and I am super militant about this—and then, you know, I also don’t like to continue [dual antiplatelet therapy] more than what I have to.”
    Gastroenterology
    [Gastroenterologist 1] “I think, in general, PCPs or other physicians are pretty aware of the risk, and the patients, by the time they come to us, they are already on PPIs. So, I don’t usually make—I don’t usually start PPIs just for gastroprotection. I think it’s more because I don’t feel like I need to because they are already on it, typically.”
    [Gastroenterologist 2] “If somebody comes in to see me for a GI problem, on my checklist is not to see if they are at risk for bleeding ulcer or complicated peptic ulcer disease. Now, if they bring to my attention any upper GI symptoms, that will be a part of my evaluation, especially if it’s peptic symptoms or, again, any reflux symptoms. But every patient that I see in clinic, I don’t—you know, like in primary care they make sure somebody’s mammogram is up to date. I don’t look to see if a—I don’t assess their risk for developing a bleeding ulcer and look to see if they are on appropriate gastroprotection.”
    Vascular surgery
    [Vascular surgeon 3] “I generally do not prescribe them [PPIs] for my patients in an outpatient setting, so short of those people who get them in the perioperative setting, I am not initiating treatment for patients.”
    • GERD = gastroesophageal reflux disease; GI = gastrointestinal; PCP = primary care physician; PPI = proton pump inhibitor; ST = section on an electrocardiogram between S wave and T wave.

    • View popup
    Table 3.

    Participant Reference to Possible Adverse Effects Associated With PPI Use

    Reference, No. (%)Primary Care (n = 5)Cardiology (n = 4)Gastroenterology (n = 3)Vascular Surgery (n = 3)
    Any mention of possible adverse effects5 (100)2 (50)3 (100)1 (33.3)
    Clostridioides difficile or other enteric infection4 (80)1 (25)1 (33.3)1 (33.3)
    Dementia4 (80)0 (0)3 (100)0 (0)
    Pneumonia3 (60)2 (50)1 (33.3)1 (33.3)
    Chronic kidney disease3 (60)1 (25)2 (66.7)0 (0)
    Bone disease3 (60)0 (0)2 (66.7)1 (33.3)
    • PPI = proton pump inhibitor.

Additional Files

  • Tables
  • Visual abstract - link below

    Visual abstract. What barriers exist when a physician wants to prescribe a proton pump inhibitor to a patient at high risk for upper GI bleeding?

    • Kurlander_visualabstract_20.1.png -

      PNG file

  • Supplemental materials

    Supplemental Appendix 1. Final Interview Guide 

    Supplemental Appendix 2. Detailed Description of Qualitative Analysis and Coding Process 

    Supplemental Table 1. Supporting Quotes for Knowledge 

    Supplemental Table 2. Supporting Quotes for Decision Processes 

    Supplemental Table 3. Supporting Quotes for Professional Role 

    • Kurlander.pdf -

      PDF file

PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 20 (1)
The Annals of Family Medicine: 20 (1)
Vol. 20, Issue 1
1 Jan 2022
  • Table of Contents
  • Index by author
  • Plain Language Summaries
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding
Jacob E. Kurlander, Danielle Helminski, Alex N. Kokaly, Caroline R. Richardson, Raymond De Vries, Sameer D. Saini, Sarah L. Krein
The Annals of Family Medicine Jan 2022, 20 (1) 5-11; DOI: 10.1370/afm.2734

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding
Jacob E. Kurlander, Danielle Helminski, Alex N. Kokaly, Caroline R. Richardson, Raymond De Vries, Sameer D. Saini, Sarah L. Krein
The Annals of Family Medicine Jan 2022, 20 (1) 5-11; DOI: 10.1370/afm.2734
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study
  • Google Scholar

More in this TOC Section

  • Neighborhood Determinants of Primary Care Access in Virginia
  • Proactive Deprescribing Among Older Adults With Polypharmacy: Barriers and Enablers
  • Artificial Intelligence Tools for Preconception Cardiomyopathy Screening Among Women of Reproductive Age
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Acute illness
    • Prevention
  • Methods:
    • Qualitative methods
  • Other research types:
    • Health services
  • Core values of primary care:
    • Coordination / integration of care

Keywords

  • proton pump inhibitors
  • gastroprotection
  • gastrointestinal bleeding
  • prevention
  • barriers

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine